
Outpace Bio
Revolutionizing cell therapy with protein design, Outpace reprograms immune cells to make better decisions inside patients, enhancing cell therapy persistence and overcoming biology barriers to cancer treatment.
Employees
Enterprise value
$576—864m
Authorizing premium user...